Clinical Trial Update: Study Evaluating Venetoclax in Subjects With Hematological Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for venetoclax in hematological malignancies at phases 1 and 2; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Multiple Myeloma
• Non-hodgkin Lymphoma
• Small Lymphocytic Lymphoma

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Non-Hodgkin Lymphoma (NHL), Multiple Myeloma (MM) | Phase 1, Phase 2 | Status: COMPLETED